233 related articles for article (PubMed ID: 29165707)
1. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
Stecher CW; Fofana HKM; Madsen H; Wilson S; Keita AD; Landouré A; Traoré MS; Vennervald BJ; Reimert CM; Sacko M
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):316-324. PubMed ID: 29165707
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity.
Reimert CM; Mshinda HM; Hatz CF; Kombe Y; Nkulila T; Poulsen LK; Christensen NO; Vennervald BJ
Am J Trop Med Hyg; 2000 Jan; 62(1):19-28. PubMed ID: 10761720
[TBL] [Abstract][Full Text] [Related]
3. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
[TBL] [Abstract][Full Text] [Related]
4. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
[TBL] [Abstract][Full Text] [Related]
5. Effect of praziquantel on the immature stages of Schistosoma haematobium.
Botros S; Pica-Mattoccia L; William S; El-Lakkani N; Cioli D
Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
[TBL] [Abstract][Full Text] [Related]
7. High Efficacy of Praziquantel in
Houmsou RS; Wama BE; Agere H; Uniga JA; Amuta EU; Kela SL
Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e304-e310. PubMed ID: 30607270
[TBL] [Abstract][Full Text] [Related]
8. Bladder outlet obstruction; a rare complication of the neglected schistosome, Schistosoma haematobium: two case reports and public health challenges.
Agbor VN; Njim T; Mbolingong FN
BMC Res Notes; 2016 Nov; 9(1):493. PubMed ID: 27876076
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment.
Botros SS; Hammam OA; El-Lakkany NM; El-Din SH; Ebeid FA
J Parasitol; 2008 Apr; 94(2):386-94. PubMed ID: 18564739
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
13. [Dynamics of Egg Excretion of
Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed.
Silva IM; Pereira Filho E; Thiengo R; Ribeiro PC; Conceição MJ; Panasco M; Lenzi HL
Rev Inst Med Trop Sao Paulo; 2008; 50(6):343-6. PubMed ID: 19082376
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Evolution of Pediatric Urinary Schistosomiasis after Treatment with Praziquantel in a Highly Endemic Area.
Bocanegra C; Pintar Z; Mendioroz J; Serres X; Gallego S; Nindia A; Aznar ML; Soriano-Arandes A; Salvador F; Gil E; Sikaleta N; Moreno M; Molina I
Am J Trop Med Hyg; 2018 Oct; 99(4):1011-1017. PubMed ID: 30141396
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B; Coulibaly JT; Hatz C; Keiser J
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.
Dejon-Agobé JC; Edoa JR; Honkpehedji YJ; Zinsou JF; Adégbitè BR; Ngwese MM; Mangaboula A; Lell B; Woldearegai TG; Grobusch MP; Mordmüller B; Adegnika AA
Parasit Vectors; 2019 Dec; 12(1):577. PubMed ID: 31823806
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
[TBL] [Abstract][Full Text] [Related]
20. Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine.
Leutscher PD; Reimert CM; Vennervald BJ; Ravaoalimalala VE; Ramarokoto CE; Serieye J; Raobelison A; Rasendramino M; Christensen NO; Esterre P
Trop Med Int Health; 2000 Feb; 5(2):88-93. PubMed ID: 10747267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
